People · Operator
Named in public records as an officer, director or promoter · active 2009–2025 · Biotechnology, Healthtech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Synlogic, Inc. | — | Biotechnology | Series C | $186.5M | $3.3B | 2017 |
| Graybug Vision, Inc. | — | Biotechnology | Series C | $144.8M | $132.6M | 2019 |
| Cerapedics Inc | — | Biotechnology | Series B | $99.1M | $492.3M | 2009 |
| Inspire Medical Systems, Inc. | — | Healthtech | Series B | $52.5M | $309.8M | 2014 |
| Gennao Bio, Inc. | — | Biotechnology | Series B | $47.5M | $211.8M | 2021 |
| Synlogic, LLC | — | Biotechnology | Series B | $31.0M | $679.3M | 2016 |
| Noctrix Health, Inc. | — | Healthtech | Series B | $16.9M | $354.6M | 2021 |
| Perfuse Therapeutics, Inc. | — | Biotechnology | Series A | $11.0M | $319.6M | 2019 |
| Restora Medical, Inc. | — | Biotechnology | Series A | $9.5M | $23.3M | 2025 |
Chau Khuong at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Chau Khuong on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Peter Barrett | 2 | 18 |
| Ed Mathers | 2 | 11 |
| Christy Shaffer | 2 | 6 |
| Lewis Geffen | 2 | 6 |
| ANKIT MAHADEVIA | 2 | 4 |
| Mudit Jain | 2 | 4 |
| Jose Carlos Gutierrez-Ramos | 2 | 2 |
| Peter Thompson | 1 | 16 |
| Michael Powell | 1 | 14 |
| Casey Tansey | 1 | 14 |
| Corey Goodman | 1 | 13 |
| Edward Mathers | 1 | 12 |
| Jonathan Silverstein | 1 | 10 |
| Cameron Wheeler | 1 | 9 |
| Joyce Erony | 1 | 8 |
| Stephen Squinto | 1 | 8 |
| Dana Mead | 1 | 7 |
| Craig Gordon | 1 | 6 |
| Noah Kroloff | 1 | 6 |
| Elaine Jones | 1 | 6 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.